“…For example, ET-1 promotes autocrine/paracrine interactions between fibroblasts and cancer cells in prostate and HNSCC cells ( Dawson et al, 2004 ) and modulates trafficking, differentiation, and activation of tumor-associated immune cells, possibly contributing to immune evasion and resistance to immunotherapy ( Kandalaft et al, 2009 ; Grimshaw et al, 2002 ; Buckanovich et al, 2008 ; Said et al, 2011 ). ET-1 can induce expression of IL-6, CCL-2, as well as MMP and COX-2 activity, key orchestrators of inflammation-mediated cancer cell invasiveness and metastasis via AP-1 and NF-κB ( Rosano et al, 2007a , 2001 , 2007b ; Sutcliffe et al, 2009 ; Grimshaw et al, 2002 , 2004 ; Said et al, 2011 ; Browatzki et al, 2007 ; Spinella et al, 2007 ). Recently, we reported that tumor ET-1 triggers inflammation in the lung soon after the cancer cells lodged at this site and thus sets up a vicious cycle wherein inflammatory cells would enhance and facilitate the process of metastatic colonization ( Said et al, 2011 ) ( Fig.…”